Pooled Data from Trials Comparing Degarelix with LHRH Agonist in Men with Advanced Prostate Cancer

Pooled Data from Trials Comparing Degarelix with LHRH Agonist in Men with Advanced Prostate Cancer

Laurence Klotz, MD
Professor of Surgery, University of Toronto
Urologic Oncologist, Sunnybrook Health Sciences Centre

SEE RELATED CONTENT:

Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist - Abstract

Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists - Abstract